Pharmaceuticals, Biotechnology and Life Sciences
House Speaker Paul Ryan pulled the American Health Care Act of 2017 (AHCA) from a vote on Friday, which was designed to repeal the Affordable Care Act of 2010 (ACA), known as Obamacare.
Painkillers considered harmless by the general public are associated with increased risk of cardiac arrest, according to research published today in the March issue of European Heart Journal – Cardiovascular Pharmacotherapy.
PureTech Health said on Friday that it will advance with Novartis two clinical-stage programmes targeting the mechanistic target of rapamycin complex 1 (mTORC1) pathway.
Digital Pharmacist Inc., a digital health company, has acquired PocketRx, a mobile app that allows patients to manage their prescriptions.
EMD Serono, U.S. company focused on specialty care has received U.S. Food and Drug Administration (FDA) approval for its rare skin cancer drug.
Latino population in the United States of America have higher rates of cardio-metabolic diseases than in rest of the population, said David Kerr, director of Innovation and Research for the William Sansum Diabetes center.
Three of Europe’s top drugmakers face critical verdicts from U.S. regulators next week, with Sanofi <SASY.PA> and Roche <ROG.S> likely to win approvals for two new products, while GlaxoSmithKline <GSK.L> braces for a potential generic rival.
Teva Pharmaceutical Industries <TEVA.TA> may fire as many as 6,000 workers worldwide as part of a multi-year efficiency plan, Israel’s Calcalist news website reported on Thursday.
Futura medical, healthcare company focused on advanced transdermal technology, has announced its preliminary results for the year 2016.
A major research has been initiated, which will enable researchers to gain valuable insights to support advances in the development of new medicines for a wide range of serious and life threatening diseases.